Latest News and Press Releases

WallabyPhenox treats first U.S. patient in PIANO IDE trial using p48 & p64 MW HPC flow diverters for intracranial aneurysms.

Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Decentralized Clinical Trials: Global Markets" has been added to ResearchAndMarkets.com's offering. The Decentralized Clinical Trials Market is...

The global market for decentralized clinical trials (DCTs) was valued at $8.8 billion in 2024 and is projected to reach $18.8 billion by the end of 2030.

MALVERN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights

Science 37 launches its dedicated Pediatrics Department, reinforcing the company’s commitment to advancing pediatric research.

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

MALVERN, Pa., March 16, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

Conventional chemo hits walls of resistance, brutal toxicity, and minimal progress. PRP changes the game.